Apremilast
Composition
The formulation contains Apremilast 30 mg with lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, and magnesium stearate as the active ingredient.
Indications
Indicated for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis in adults.
Side effects
Common side effects include diarrhea, nausea, headache, upper respiratory tract infection, and weight loss.
Precautions
Monitor for weight loss, depression, and suicidal thoughts; use with caution in patients with a history of depression or severe gastrointestinal disorders; adjust dose in severe renal impairment.
Contraindications
Contraindicated in patients with a known hypersensitivity to Apremilast.
Dosage and administration
The recommended dosage is usually 30 mg orally twice daily, titrated from an initial dose of 10 mg once daily.
Countries
Available globally.
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai